Symposium 20: Pharmacological treatment of the patient with Non-Alcoholic Fatty Disease (NAFLD)
EGHNA, has high prevalence and is strongly related to obesity and diabetes, with great impact at the health level since it is one of the largest causes of end-stage liver disease and transplantation. There are no specific drugs approved for its treatment, only lifestyle changes show benefits: food...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Sello Editorial Lugones
2022-09-01
|
| Series: | Revista de la Sociedad Argentina de Diabetes |
| Subjects: | |
| Online Access: | https://revistasad.com/index.php/diabetes/article/view/647 |